Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Metformin

EU orphan designation number: EU/3/16/1803   
Active ingredient: Metformin
Indication: Treatment of progressive myoclonic epilepsy type 2 (Lafora disease)
Sponsor: Consorcio Centro de Investigación Biomédica en Red M.P.
Instituto de Salud Carlos III, C/ Monforte de Lemos 3-5, Pabellón 11 Planta 0, (28029) Madrid, España

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/12/2016 Orphan designation EMA/OD/179/16 (2016)8703 of 12/12/2016
9/10/2017 Change of name and/or address of sponsor